PLTR - Jim Cramer: This Industrial Company Is 'Absolutely Terrific' Recommends Buying Modine Manufacturing | Benzinga
On CNBC's “Mad Money Lightning Round,” Jim Cramer believes in Moderna, Inc. (NASDAQ:MRNA).
On May 14, Evercore ISI Group analyst Cory Kasimov initiated coverage on Moderna with an In-Line rating and announced a price target of $120.
The “Mad Money” host likes Mind Medicine (MindMed) Inc. (NASDAQ:MNMD). “Anything that makes it so that there's ways to be able to get rid of pain and do good without getting people hooked, I am all in on. Doesn't necessarily mean it will make a lot of money, I don't care,” he added.
On May 13, Oppenheimer analyst Francois Brisebois reiterated Mind Medicine ...